about
Design and Synthesis of Fast-Degrading Poly(anhydride-esters).Synthetic biodegradable functional polymers for tissue engineering: a brief review.Advanced drug delivery systems of curcumin for cancer chemopreventionAccelerated in-vitro release testing methods for extended-release parenteral dosage forms.Current advances in sustained-release systems for parenteral drug delivery.Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours.Biomaterials approaches to treating implant-associated osteomyelitis.Preparation and evaluation of rotigotine-loaded implant for the treatment of Parkinson's disease and its evolution study.Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery.Novel 4-arm poly(ethylene glycol)-block-poly(anhydride-esters) amphiphilic copolymer micelles loading curcumin: preparation, characterization, and in vitro evaluation.Synthesis and Characterization of Salicylic Acid-Based Poly(Anhydride-Ester) CopolymersSilicon micro- and nanofabrication for medicinePoly(ortho ester amides): acid-labile temperature-responsive copolymers for potential biomedical applicationsTunable drug release profiles from salicylate-based poly(anhydride-ester) matrices using small molecule admixtures.Biodegradable polyesters containing ibuprofen and naproxen as pendant groupsBioerodible system for sequential release of multiple drugs.Concurrent release of admixed antimicrobials and salicylic acid from salicylate-based poly(anhydride-esters).Role of in vitro release models in formulation development and quality control of parenteral depots.Polymeric drug delivery systems for localized cancer chemotherapy.Drug delivery in soft tissue engineering.Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors.Recent advances in polymeric microspheres for parenteral drug delivery--part 1.Intravitreal devices for the treatment of vitreous inflammation.The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.Biodegradable polymers for targeted delivery of anti-cancer drugs.Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders.Physical insights into salicylic acid release from poly(anhydrides).A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matrices.Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis.Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles.Quantitative and qualitative toxicological evaluation of thiol-ene "click" chemistry-based polyanhydrides and their degradation products.Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to rats.Development and in vitro-in vivo evaluation of polymeric implants for continuous systemic delivery of curcumin.Radiofrequency-triggered release for on-demand delivery of therapeutics from titania nanotube drug-eluting implants.Current development of biodegradable polymeric materials for biomedical applicationsBiomass Derived and Biomass Inspired Polymers in Pharmaceutical ApplicationsSynthesis and Controlled Release Behavior of Biodegradable Polymers with Pendant Ibuprofen Group
P2860
Q33635797-D9E09209-3BB1-49F0-B103-B714A9B47D0FQ35124614-0BE5F7FF-AD10-4889-BC6E-08FCD335DA83Q35150975-6F7FD74D-73F6-4AB9-A240-CC5A0116F7B3Q36129913-02F22F86-D6AF-44B9-8965-FE5271CA6EABQ36316931-E25F6FE2-7B20-489F-8AFA-2DE3791CDD9EQ36327049-759858AB-B94A-4FA7-B1B0-F12CE064F59CQ36555710-A5B2A2A8-FE38-4F49-A8F8-3AFEAC6EB0B6Q36938097-307260DA-18A9-4C24-BF33-34EE97592ADEQ36957938-DA223038-F6F3-4E16-B61C-24420D3D6292Q37043977-731EB5A6-E7AF-4745-BF68-B1F4A14E36D0Q37096715-77EB9559-AE71-4F81-8005-713DF24BBAE7Q37184228-73075ABD-58CC-485E-9DCE-BDC5E897E616Q37196562-8CF8025A-9F10-4D23-89A1-043ADA8A4E37Q37196738-FDD6BB0B-559F-42E6-A145-B523C4EABEE2Q37266996-929C3FDF-0704-4C82-BF3F-5401E6C888B7Q37362564-186F6EFA-07EE-4A4F-903C-7C8FC513EA7EQ37399847-4E13530D-3043-40E1-8E69-F6EDADC0F011Q37639309-E747CE4D-5FDC-41EB-8D6A-1C120D5544B1Q37739481-6E107D79-E219-4869-BFB1-83B0F3E2AE09Q37890406-76B4FCB4-E16E-4036-BFBE-56AC1AD67A31Q37908136-D415AA4B-9EF0-4F6D-976A-0A1593817C71Q38029806-7BD1D586-3DF6-4935-AD2C-58221C80C0DCQ38044373-83247102-8EDF-4B5B-89B7-EB77A8EF9A69Q38722460-E0252AC1-AF31-41C3-B54D-E20278AE29C0Q38777436-A34D8EC4-A36E-43DA-B2E6-D00DF84AC2E4Q38857113-F70DE53B-B45D-44D1-8FB4-BB1E2A45327FQ40187063-330C316F-69BC-4F98-B6A0-A098C4FAE9E4Q40362968-A232E614-8259-4F45-95B9-19B2026FD48BQ41809466-2C5105CD-BD42-4AE7-962F-72FA46337317Q42242342-6D1734D1-588F-483C-A743-99E824ADC2BBQ42812415-6AA0797C-BC76-46D6-B74A-9CF4AEE64C8CQ44888499-A72426AA-63BF-48AA-9C7C-89E7A71AB4BEQ45770364-48588D0F-51FF-4C47-A97B-AD2CA4FEC023Q46762401-4AD5D3AC-04F7-4ED2-A6C0-836759C009F5Q57070270-0FC03684-C02C-4676-82B2-B2203692655BQ58484641-4C4C7D2D-2AAD-44DC-8E2E-9B035B21FEF7Q59124912-45731EB7-C64E-4292-938F-D261402EB9EF
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Role of polyanhydrides as localized drug carriers.
@ast
Role of polyanhydrides as localized drug carriers.
@en
type
label
Role of polyanhydrides as localized drug carriers.
@ast
Role of polyanhydrides as localized drug carriers.
@en
prefLabel
Role of polyanhydrides as localized drug carriers.
@ast
Role of polyanhydrides as localized drug carriers.
@en
P2093
P1476
Role of polyanhydrides as localized drug carriers
@en
P2093
Jay Prakash Jain
Neeraj Kumar
Sweta Modi
P304
P356
10.1016/J.JCONREL.2004.12.021
P407
P577
2005-04-01T00:00:00Z